The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.
This article was originally published on MedicalXpress.com
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
You may also be interested in:
The Latest
Why stress-related illness is so hard to diagnose, and how a patient-centred playful approach can help
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
The Latest
Avoiding Common Relationship Mistakes for a Happier Love Life
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
The Latest
Microneedling Services in Edmonton: Benefits, Treatment Cost, and How It Works
Microneedling is a revolutionary skincare treatment that has gained popularity in recent years due to its numerous benefits, including reducing the appearance of scars, wrinkles, and acne, and promoting collagen production. Edmonton, the bustling capital […]
Read More:
-
At the height of the COVID-19 pandemic, firearm violence surpassed motor vehicle accidents as the leading cause of death among US children. A new study [...]
-
New Curtin University research has revealed child food insecurity in developed countries is not solely driven by poverty but is also strongly influenced by factors [...]
-
Researchers at Oregon Health & Science University’s Center for Mental Health Innovation have discovered that maternal diet during pregnancy, specifically during the third trimester, may [...]
